• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Cannabis Market
    Cannabis News
    Cannabis Stocks
    • Cannabis Market
    • Cannabis News
    • Cannabis Stocks
    cannabis investing

    BLOCKStrain Technology Appoints Dr. Gina Conte as Director of Genetics

    Anwesha Sengupta
    Apr. 11, 2019 06:01AM PST
    Cannabis Investing News
    OTC: BKKSF

    BLOCKStrain Technology Corp. (TSXV:DNAX) (OTC: BKKSF) (“BLOCKStrain”), creator of the first Blockchain-secured, fully-integrated IP tracking platform for the cannabis industry, today announced it has appointed award-winning geneticist Dr. Gina Conte to the role of Director of Genetics. Dr. Conte brings an extensive amount of expertise to her role, and will provide leadership and direction in business development.

    BLOCKStrain Technology Corp. (TSXV:DNAX) (OTC: BKKSF) (“BLOCKStrain”), creator of the first Blockchain-secured, fully-integrated IP tracking platform for the cannabis industry, today announced it has appointed award-winning geneticist Dr. Gina Conte to the role of Director of Genetics. Dr. Conte brings an extensive amount of expertise to her role, and will provide leadership and direction in business development.

    “Dr. Conte brings significant experience and insight to BLOCKStrain, and will provide tremendous strength to our growing cadre of cannabis-based science experts,” said CEO, Robert Galarza. “Her past research into this field has provided forward momentum and knowledge around the genetics and profiling of cannabis strains, and we are excited to have her as a key part of our team as we work diligently to provide both industry participants and consumers with best-in-class technology solutions.”

    “BLOCKStrain’s mission to increase transparency and integrity in the cannabis industry aligns strongly with my ongoing interest and specialization in the genetics of cannabis strains,” said Dr. Conte. “I look forward to working closely with BLOCKStrain as they continue to innovate with this industry-best technology platform.”

    Dr. Conte is currently the Chief Scientific Officer at Lighthouse Genomics Inc. where she leads the company in the development and implementation of genomic services for the certification and verification of cannabis strains. Dr. Conte is also Co-founder and Chief Scientific Officer of Illuminate Data Science Inc. where she leads a research program to model the effects of cannabis strains and products on the therapeutic efficacy and experience using innovative machine learning.

    In connection with this appointment BLOCKStrain has agreed to grant Dr. Conte stock options to acquire up to 250,000 common shares in the capital of BLOCKStrain, subject to the terms of a stock option agreement to be entered into by the parties.

    About BLOCKStrain:

    BLOCKStrain has developed the first integrated blockchain platform to register and track intellectual property in the cannabis industry. BLOCKStrain’s technology allows cannabis growers and breeders to identify and secure rights to their intellectual property. It also streamlines the administrative process and reduces the costs of genetic and mandatory quality-control testing for legal cannabis. BLOCKStrain’s technology is proprietary, immutable and cryptographically secure, thereby establishing a single-source, accurate, validated, and permanent account for cannabis strains from ownership to market.

    Forward-Looking Information:

    The forward-looking information in this news release is based upon expectations, estimates, projections, assumptions and views of future events which management believes to be reasonable in the circumstances. Forward-looking information includes estimates, plans, expectations, opinions, forecasts, projections, targets, guidance or other statements that are not statements of fact. Forward-looking statements in this news release include statements regarding: Gina L. Conte’s anticipated role with BLOCKStrain and that her expertise will benefit BLOCKStrain. Forward-looking information necessarily involves known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; loss of markets; changes to the growth and size of the cannabis industry;future legislative and regulatory developments; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the cannabis industry in Canada generally; the ability of BLOCKStrain to implement its business strategies; competition; and other risks. These forward-looking statements are made as of the date hereof and BLOCKStrain disclaims any intent or obligation to update publicly any forward-looking statements, whether as a result of new information, future events or results or otherwise, except as required by applicable securities laws.

    NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

    For further information: BLOCKStrain Technology Corp. Robert Galarza, Chief Executive Officer and Director; Investor Inquiries: Crystal Quast Bullseye Corporate, 1-844-656-3629, Quast@BullseyeCorporate.com; Media Inquiries: Corey Herscu RNMKR, 416-410-0404, corey@rnmkr.agency

    Click here to connect with BLOCKStrain Technology Corp. (TSXV:DNAX) (OTC: BKKSF) for an Investor Presentation. 

    Source: www.newswire.ca

    robert galarzacannabis investingblockstrain technology corp.tsxv:dnaxotc: bkksf
    The Conversation (0)

    Go Deeper

    AI Powered
    Banxa Holdings Provides Update on Previously Announced Plan of Arrangement with OSL Group

    Banxa Holdings Provides Update on Previously Announced Plan of Arrangement with OSL Group

    BioSig Technologies Appoints Mr. Ferdinand Groenewald to Position of Interim Chief Financial Officer and Principal Accounting Officer

    BioSig Technologies Appoints Mr. Ferdinand Groenewald to Position of Interim Chief Financial Officer and Principal Accounting Officer

    Latest News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Cannabis Investing News Stocks

    The Tinley Beverage Company

    TNY:CNX

    extractX

    Hygrovest Limited

    HGV:AU

    Lords & Company Worldwide Holdings

    LRDS:CNX
    Lords & Company Worldwide Holdings Logo

    Adastra Holdings

    XTRX:CNX

    MMJ Group Holdings

    MMJ:AU
    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×